EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Super-Enhancer-Driven TCF4 Orchestrates Neuroblastoma Metastasis by Sphingolipid-Dependent Membrane Remodeling and ITGB1-FAK Activation

Enzhe Lou, Liling Jiang, Yueyuan Zheng iD, Ran Zhuo, Huan Zhou, Shiwen Hu, Chunxia Shi, Haichuan Zhang, Xinyue Li, Lizhen Jiang, Qiong Mao, Aochu Liu und 4 weitere

Neuro-Oncology · 2026

DOI: 10.1093/neuonc/noag021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Enzhe Lou und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Neuroblastoma, Transcription Factor 4, Super Enhancers, Focal Adhesion Kinase 1. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, L.L.J. Shenzhen Medical Research Fund, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metastasis remains a critical determinant of survival in neuroblastoma (NB), yet the role of transcriptional dysregulation, particularly super-enhancer (SE)-mediated transcriptional control in this process has not been elucidated. The aim of this study is to identify the SE-driven transcription factors involved in the metastasis of NB and potential targeted drugs.

Methods

The metastatic SE-driven Transcription Factor 4 (TCF4) was screened and identified by integrating bioinformatic analyses of H3K27ac ChIP-seq and scRNA-seq. The effect of TCF4 on NB cell metastasis was evaluated through in vivo and in vitro functional experiments. The molecular mechanism of TCF4 was investigated by the study of targeted CUT&Tag and transcriptome sequencing.

Results

TCF4 is associated with poor prognosis in patients and significantly promotes the metastasis ability of NB cells both in vivo and in vitro. Mechanistically, TCF4 transcriptionally activates SPTLC1, a pivotal enzyme in sphingolipid biosynthesis, to promote ganglioside GM3 synthesis. GM3 orchestrates membrane architecture remodeling, thereby modulating ITGB1 membrane localization and activation, which subsequently potentiates FAK signaling. Notably, we demonstrate that the HDAC6 inhibitor ACY-1215 suppressed NB malignancy by destabilizing TCF4 protein.

Conclusions

Our findings indicate that SE-driven TCF4 can orchestrate metastatic transcriptional networks to maintain NB malignancy and propose ACY-1215 as a translational therapeutic candidate for clinical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaTranscription Factor 4Super EnhancersFocal Adhesion Kinase 1SphingolipidsIntegrin beta1Cell MembraneHumansAnimalsMiceGene Expression Regulation, NeoplasticCell Line, TumorTumor Cells, Cultured

Stichwörter der Autor:innen

TCF4neuroblastomasuper-enhancertargeted therapiestranscription factor

Substanzen

Transcription Factor 4TCF4 protein, humanFocal Adhesion Kinase 1SphingolipidsIntegrin beta1PTK2 protein, human

Autor:innen und Institutionen

  • The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
  • Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong,…
  • Clinical Big Data Research Center, Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.
  • Institute of Pediatric Research, Children's Hospital of Soochow University, Suzhou, China.

ORCID-Profile: Yueyuan Zheng, Jian Pan, Xianping Shi

Förderung

  • National Natural Science Foundation of China
  • L.L.J. Shenzhen Medical Research Fund
  • Natural Science Foundation of Guangdong Province
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Lou, E., Jiang, L., Zheng, Y., Zhuo, R., Zhou, H., Hu, S., Shi, C., Zhang, H., Li, X., Jiang, L., Mao, Q., Liu, A., Liu, B., Fang, J., Pan, J., & Shi, X. (2026). Super-Enhancer-Driven TCF4 Orchestrates Neuroblastoma Metastasis by Sphingolipid-Dependent Membrane Remodeling and ITGB1-FAK Activation. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag021

Vancouver

Lou E, Jiang L, Zheng Y, Zhuo R, Zhou H, Hu S, et al. Super-Enhancer-Driven TCF4 Orchestrates Neuroblastoma Metastasis by Sphingolipid-Dependent Membrane Remodeling and ITGB1-FAK Activation. Neuro-Oncology. 2026. doi:10.1093/neuonc/noag021

BibTeX
@article{Lou2026,
  author = {Lou, Enzhe and Jiang, Liling and Zheng, Yueyuan and Zhuo, Ran and Zhou, Huan and Hu, Shiwen and Shi, Chunxia and Zhang, Haichuan and Li, Xinyue and Jiang, Lizhen and Mao, Qiong and Liu, Aochu and Liu, Bingyuan and Fang, Jinxin and Pan, Jian and Shi, Xianping},
  title = {Super-Enhancer-Driven TCF4 Orchestrates Neuroblastoma Metastasis by Sphingolipid-Dependent Membrane Remodeling and ITGB1-FAK Activation},
  journal = {Neuro-Oncology},
  year = {2026},
  doi = {10.1093/neuonc/noag021}
}
Kostenlos starten →